FTC Should Expand Study Of PBM Business Practices, Senators Say
This article was originally published in The Pink Sheet Daily
The commission should initiate a second round of data collection focusing on contracts between PBMs and manufacturers, a letter signed by seven senators states. FTC also is urged to collect data on PBM pricing practices for generics.
You may also be interested in...
The suit focuses on Express Scripts' administration of the New York state employee health plan pharmacy benefit. New York AG alleges that PBM overcharged for generic drugs, "disguised" manufacturer rebates and illegally sold plan data to manufacturers and data collection services.
The Federal Trade Commission will study whether using a PBM-owned mail order pharmacy costs more than using a non-PBM mail order or retail pharmacy. The study was mandated by the Medicare Rx law.
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.